Formulation and evaluation of microemulsion containing griseofulvin
Keywords:
griseofulvin, microemulsion, particle size, zeta potential, scanning electron microscopyAbstract
The aim of the following research is to formulate a microemulsion containing drug Griseofulvin. Griseofulvin is an antifungal agent which inhibits the mitosis. It is recommended orally for treatment of fungal disease. It is used to treat skin infections such as jock itch, athletes foot and ringworm. Also it is used to treat the fungal infections of scalp, toenails and fingernails. Griseofulvin is a BCS II class drug. It is highly lipophilic poorly soluble drug with low oral bioavailability. The present aim was to increase the solubility by microemulsion system for topical delivery. Microemulsions are clear, stable and isotropic liquid. They show advantages such as spontaneous preparation, scale up, ease of preparation, improving drug solubility of hydrophobic drugs. It is also used to increase the bioavailability of drug. These also aim at controlling the bioavailability of various drug molecules. The review put forward the development in microemulsion containing system. They improve solubility, chemical stability and oral bioavailability of poorly water soluble drugs. There is formulation of four different batches. The batches differ in quantity of surfactant and co- surfactants.
Downloads
References
International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 79. Lyon, France: IARC Press; 2001. p. 75-89.
Tanaka Y, Waki R, Nagata S. Species differences in the dissolution and absorption of
griseofulvin and albendazole, biopharmaceutics classification system class II drugs, in the gastrointestinal tract. Drug Metab Pharmacokinet 2013;28(6):485-90.
Aggarwal N, Goindi S, Khurana R. Formulation, characterization and evaluation of an optimized microemulsion formulation of griseofulvin for topical application. Colloids Surf B Biointerfaces 2013;105:158-66.
Moghimipour E, Salimi A, Hassanvand S. Permeability assessment of griseofulvin microemulsion through rat skin. Int J Pharm Chem Biol Sci 2013;3(4):1061-5.
U.S. National Library of Medicine. Griseofulvin-Griseofulvin Tablet; 2016. Available from: http://www.dailymed.nlm.nih.gov/dailymed/ drugInfo.cfm?setid=6149c044-58bb-402c-a4b5-18b96dd9b3b9. [Last accessed on 2016 Jan 11].
Lahenmeier DW. Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity. J Occup Med Toxicol 2008;3:26.
Shinde U, Pokharkar S, Modani S. Design and evaluation of microemulsion gel system of nadifloxacin. Indian J Pharm Sci 2012;74(3):237-47.
Kumar A, Kushwaha V, 11. Júnior AA, Baldo JB. The behavior of zeta potential of silica suspensions. N J Glass Ceram 2014;4:29-37
Sharma PK. Pharmaceutical microemulsion: Formulation, characterization and drug deliveries across skin. Int J Drug Dev Res 2014;6(1):1-21.
T.P. Hoar and J.H. Schulman. Transparent water-in-oil dispersions, the oleopathic hydro micelle. Nature 1943; 152: 102–103.
J. H. Schulman et al. Mechanism of formation and structure of micro emulsions by electron microscopy. The Journal of Physical Chemistry 1959; 63: 1677–1680.
Danielsson and B. Lindman. The definition of a microemulsion, Colloids and Surfaces 1981; 3: 391–392.
Shinoda K and Lindman B. Organised surfactant systems: Microemulsions. Langmuir 1987; 3: 135–149.
M. Jayne Lawrencea and Gareth D. Reesb. Microemulsion-based media as novel drug delivery systems. Advanced Drug Delivery Reviews 2000; 45: 89–121.
Kumar. K. Senthil et al. Microemulsions as Carrier for Novel Drug Delivery: A Review. International Journal of Pharmaceutical Sciences Review and Research 2011; 10: 37-45.
Patel R. Mrunali. Microemulsions: As Novel Drug Delivery Vehicle. 2007; 5.
Madhav. S and Gupta. D. A review on microemulsion based system. International Journal of Pharmaceutical Sciences and Research 2011; 2 (8): 1888.
Shiokawa T. et al. Effect of Polyethylene Glycol Linker Chain Length of Folate-Linked Microemulsions Loading Aclacinomycin A on Targeting Ability and Antitumor Effect In itro and In vivo. Clinical Cancer Research 2005; p11.
Talegaonkar S and Mishra P. Intranasal delivery: An approach to bypass the blood brain barrier. Indian Journal of Pharmacology 2004; 36: 140-147.
Hasse. A. and Keipert S. Development and characterisation of microemulsions for ocular application. European Journal of Pharmaceutics and Biopharmaeutics 1997; 43; 179–183.
Malmsten. M. Microemulsions in pharmaceuticals In Handbook of Microemulsion. Science and Technology. Marcel Dekker. Inc. New York. 1999; p 755.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
